ArticleMediterranean journal of rheumatology2026
Association Between Prognostic Nutritional Index and Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study.
Article in Mediterranean journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prognostic nutritional index (PNI), derived from serum albumin and lymphocyte count, reflects immunonutritional status and may be influenced by systemic inflammation. This study examined the association between PNI and disease activity in rheumatoid arthritis (RA). A total of 730 patients fulfilling the 2010 ACR/EULAR criteria were retrospectively analysed. Demographic, clinical, and laboratory data were collected; disease activity and disability were assessed using the DAS28-CRP and Health Assessment Questionnaire (HAQ). Correlation analyses, multivariable linear regression, ROC analyses, subgroup testing, and mediation analyses were performed. The mean age was 56.2±12.5 years and 76.3% were women. Median DAS28-CRP was 3.38, with 11.2% classified as having high disease activity. Mean PNI was 54.0±5.34. PNI was significantly lower in patients with high DAS28-CRP and in severe HAQ categories (p<0.01). PNI correlated negatively with DAS28-CRP, HAQ, CRP, ESR, and disease duration (all p<0.01). However, PNI was not independently associated with DAS28 or HAQ in adjusted regression models, whereas CRP and ESR remained significant predictors. ROC performance of PNI was modest (AUC 0.65-0.67). Associations were stronger in older adults and in men, and mediation analyses indicated that CRP and ESR largely explained the PNI-DAS28 relationship. Lower PNI was associated with greater RA burden, but this association appears to be largely driven by systemic inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.